Invectys focuses on the development of innovative anti-cancer therapeutic approaches in immunotherapy. It is backed by French and international private investors…
HLA-G: from pregnancy to tumors Invectys Inc. targets a powerful immune checkpoint named HLA-G. HLA-G is a non-classical MHC class I molecule normally only expressed…
